| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rain Oncology Inc. | VP of Finance & Admin | Stock Option (Right to Buy) | 65.3K | Feb 15, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | Mar 14, 2024 | 0 | $0 | 3 | Mar 15, 2024 | Chief Financial Officer |
| RAIN | Rain Oncology Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | VP of Finance & Admin |
| RAIN | Rain Therapeutics Inc. | Jan 7, 2022 | 1 | $0 | 4 | Feb 4, 2022 | VP of Finance and Administration |
| RAIN | Rain Therapeutics Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Officer |